Jeffrey Wallin

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2023-10-26

Top Assignees for applications by Jeffrey Wallin

The entities that hold a legal rights for patent applications filed by inventor Wallin Jeffrey:

Genentech, Inc. 6 South San Francisco, CA United States
F. HOFFMAN-LA ROCHE AG 1 Basel, Switzerland

Recent patent applications by Wallin Jeffrey

Jeffrey Wallin from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-26

US20230340613A1

Chemistry; metallurgy

METHODS FOR MONITORING AND TREATING CANCER

#2 | 2019-02-07

US20190038734A1

Human necessities

METHODS FOR MONITORING AND TREATING CANCER

#3 | 2019-01-31

US20190032151A1

Chemistry; metallurgy

METHODS FOR MONITORING AND TREATING CANCER

#4 | 2018-10-04

US20180280408A1

Human necessities

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

#5 | 2016-09-29

US20160279142A1

Human necessities

COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER

#6 | 2016-02-18

US20160045515A1

Human necessities

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

#7 | 2014-02-13

US20140044706A1

Human necessities

Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

#8 | 2011-04-14

US20110086837A1

Human necessities

COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR

#9 | 2009-04-16

US20090098135A1

Human necessities

Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use

InventorID:

649831 ⎘